Search clinical trials for: identifying high risk group for suicide

Total 374935 results

Joshua Woolley
Heffter Research Institute; Usona Institute; River Styx Foundation; Stupski Foundation

Completed

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

Depression | Distress | Grief

United States
Novartis Pharmaceuticals

Completed

Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

Germany, United States, France
Asan Medical Center
Samsung Medical Center; Yonsei University; Ewha Womans University; The Catholic... and other collaborators

Unknown

Surveillance in Ulcerative Colitis: Narrow Band Image Versus Chromoendoscopy for High-risk Groups (SUNRISE-High)

Ulcerative Colitis | Dysplasia
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | CD20-Positive Neoplastic Cells Present | Refractory Mature B-Cell Non-Hodgkin Lymphoma

United States
Boston Medical Center
Centers for Disease Control and Prevention

Completed

A Medical Home-Based Intervention to Prevent Child Neglect in High-Risk Families

Child Abuse

United States
Seoul National University Hospital
Taejoon Pharmaceutical Co., Ltd.; Reyon Pharmaceutical Co., Ltd.

Completed

A Study of HCC High Risk Group Using Two Surveillance Tools

HCC

Korea, Republic of
Latin American Cooperative Oncology Group
Oncoclínicas

Withdrawn

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19 (HOPE_BRAZIL)

Sars-CoV2

Brazil
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects

Healthy

China
Karolinska University Hospital
German Breast Group; Austrian Breast & Colorectal Cancer Study Group; Swedish...

Unknown

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients (PANTHER)

Breast Cancer

Sweden, Germany, Austria
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer

Breast Carcinoma | Fallopian Tube Carcinoma | Ovarian Neoplasm | Primary Peritoneal Carcinoma

United States
Washington University School of Medicine
Centre for Global Child Health, Hospital for Sick Kids, Toronto, Canada; Department... and other collaborators

Completed

Treatment of High-Risk Moderate Acute Malnutrition Using Expanded Admission Criteria (Hi-MAM)

Malnutrition

Sierra Leone
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group; Canadian Cancer Trials Group; Southwest Oncology... and other collaborators

Completed

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

HER2 Positive Breast Carcinoma | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Breast Adenocarcinoma

United States, Canada, Peru, South Africa
University of Tennessee Medical Center

Withdrawn

Impedance Cardiography to Decrease the Risk of Preeclampsia

Preeclampsia | Chronic Hypertension Complicating Pregnancy (Diagnosis)

United States
Genentech, Inc.

Completed

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Malignant Melanoma

United States
University of Oregon
Oregon Social Learning Center

Completed

Trial of KEEP-P, a Preventive Intervention for Foster Preschoolers (KEEP-P) (KEEP-P)

Child Behavior

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer

Prostate Cancer
Assiut University

Unknown

Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients

COVID19
University of Oslo
University of Tromso; University of Minnesota; Boots Norway AS; Mills DA

Unknown

Vascular Lifestyle-Intervention and Screening in Pharmacy (VISA)

Cardiovascular Diseases | Diabetes Mellitus, Type 2 | Dyslipidemia | Hypercholesterolemia | Hypertensive Disease

Norway
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Uterine Corpus Leiomyosarcoma | Stage I Uterine Sarcoma AJCC v7

United States, Belgium, France, Spain, United Kingdom, Netherlands, Norway, Venezuela
M.D. Anderson Cancer Center
National Cancer Institute (NCI); AstraZeneca; Eastern Cooperative Oncology Group

Terminated

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

Prostate Cancer

United States
NCIC Clinical Trials Group

Completed

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

Breast Cancer

United States, Canada
NCIC Clinical Trials Group

Completed

Tamoxifen in Treating Women With High-Risk Breast Cancer

Breast Cancer

Canada
Yonsei University

Completed

Efficacy of Hemostatic Powder in Preventing Bleeding After Gastric Endoscopic Submucosal Dissection in High-risk Patients: A Prospective Randomized Control Study

High-risk Patients for Post-ESD Bleeding

Korea, Republic of
Nordic Lymphoma Group
Mundipharma Pte Ltd.; Amgen

Completed

CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis (CHIC)

Primary Disease

Denmark, Finland, Norway, Sweden
University of Pittsburgh

Withdrawn

HOPE TEAM - Clinical High Risk Group CBSST

Psychosis | Prodromal Symptoms | Prodromal Stage | Prodromal States

United States
Sellas Life Sciences Group

Unknown

WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation

Multiple Myeloma | Minimal Residual Disease | High-Risk Cancer

United States
AstraZeneca
Bristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study Group

Completed

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58)

Diabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular Event

United States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
Hoffmann-La Roche

Completed

A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy (OAK)

Non-Squamous Non-Small Cell Lung Cancer

United States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

Ovarian Carcinoma

United States
Ottawa Heart Institute Research Corporation
Bristol-Myers Squibb; Bayer; Boehringer Ingelheim; Heart and Stroke Foundation...

Completed

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events (BRUISECONTROL2)

Hematoma

Canada, Israel
Washington University School of Medicine

Completed

High Risk Youth With Poorly-controlled Diabetes

Type 1 Diabetes Mellitus

United States
Johns Hopkins University
National Eye Institute (NEI); Results Group LLC

Terminated

Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)

Age-related Macular Degeneration

United States
Korey Kennelty

Completed

Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care (ICARE)

Coronary Artery Disease | Stroke | Hypertension | Diabetes Mellitus | Atrial Fibrillation

United States
Eisai Inc.
Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization

Completed

A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors (CAMELLIA-TIMI)

Obesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular Risk

United States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
Tan Tock Seng Hospital
Frontier Healthcare Group; OneCare Medical Group

Completed

Increasing the Uptake of Influenza and Pneumococcal Vaccines Among High-Risk Adult Patients Through GP Clinics

Immunization Programs

Singapore
Shandong Provincial Hospital

Unknown

A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC

Myelodysplastic Syndromes,Acute Myeloid Leukemia

China
Groupe Francophone des Myelodysplasies
Merck Sharp & Dohme LLC

Terminated

Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure (GFM-AZA-VOR)

Myelodysplastic Syndrome

France
Second Xiangya Hospital of Central South University
Sun Yat-sen University

Unknown

Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group

Schizophrenia

China
University Hospital, Montpellier

Completed

Retrospective Analysis of Nephrotoxicity During Daptomycin Versus Vancomycin Treatments in High Risk Patients (DVN)

Surgical Site Infection | Infective Endocarditis | Mediastinitis | Infection Related to Ventricular Assist Device | Infection Related to Vascular Prothesis

France
University of Calgary
Movember Foundation

Completed

The Effects of E-mental Health Program and Job Coaching on the Risk of Major Depression in Canadian Working Men

Depression | Men

Canada
Pfizer

Terminated

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (SPIRE-2)

Cardiovascular Disease

United States, Finland, Netherlands, Spain, Belgium, Germany, Czechia, Switzerland, Denmark, Australia, United Kingdom, Korea, Republic of, Hungary, Israel, Poland, Taiwan, Mexico, Turkey, Ireland, Canada, New Zealand, South Africa, Brazi... and more
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Prostate Cancer

United States, Canada
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Promoting Tolerance to Peanut in High-Risk Children (LEAP)

Egg Allergy | Eczema | Food Allergy

United Kingdom
Gynecologic Oncology Group
National Cancer Institute (NCI)

Unknown

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

Obesity | Fatigue | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Neurotoxicity Syndrome

United States, Korea, Republic of
Universidad de Almeria

Completed

High-intensity Training for Improving Physical Performance of Aged Women (AHIITATE)

Healthy | Physical Activity | Aging | Cardiovascular Risk Factor
Swiss Pediatric Oncology Group

Completed

SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia

Cancer | Neutropenia | Fever | Pediatrics | Fever in Neutropenia

Switzerland
Celgene

Completed

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) (tnAcity)

Breast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...

United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
Seagen Inc.

Terminated

Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS

Myelodysplastic Syndrome

United States
University of Pittsburgh
University of Texas Southwestern Medical Center

Completed

Brief Intervention for Suicide Risk Reduction in High Risk Adolescents (ASAP)

Adolescent Behavior

United States
Groupe Francophone des Myelodysplasies
Novartis

Completed

A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients (LDE255)

MDS

France

Search clinical trials for: identifying high risk group for suicide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations